BR112012016749A2 - "d-aminoácido para uso no tratamento de biofilmes" - Google Patents

"d-aminoácido para uso no tratamento de biofilmes"

Info

Publication number
BR112012016749A2
BR112012016749A2 BR112012016749A BR112012016749A BR112012016749A2 BR 112012016749 A2 BR112012016749 A2 BR 112012016749A2 BR 112012016749 A BR112012016749 A BR 112012016749A BR 112012016749 A BR112012016749 A BR 112012016749A BR 112012016749 A2 BR112012016749 A2 BR 112012016749A2
Authority
BR
Brazil
Prior art keywords
amino acid
biofilm treatment
biofilm
treatment
treating
Prior art date
Application number
BR112012016749A
Other languages
English (en)
Inventor
Losick Richard
Original Assignee
President And Fellows Of Harvard Colege
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by President And Fellows Of Harvard Colege filed Critical President And Fellows Of Harvard Colege
Publication of BR112012016749A2 publication Critical patent/BR112012016749A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/31504—Composite [nonstructural laminate]
    • Y10T428/31678—Of metal
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/31504—Composite [nonstructural laminate]
    • Y10T428/31971—Of carbohydrate
    • Y10T428/31989—Of wood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/31504—Composite [nonstructural laminate]
    • Y10T428/31971—Of carbohydrate
    • Y10T428/31993—Of paper
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
    • Y10T442/20—Coated or impregnated woven, knit, or nonwoven fabric which is not [a] associated with another preformed layer or fiber layer or, [b] with respect to woven and knit, characterized, respectively, by a particular or differential weave or knit, wherein the coating or impregnation is neither a foamed material nor a free metal or alloy layer
    • Y10T442/2525—Coating or impregnation functions biologically [e.g., insect repellent, antiseptic, insecticide, bactericide, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Materials For Medical Uses (AREA)
  • Detergent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Eyeglasses (AREA)

Abstract

patente de invenção: "d-aminoácidos para uso no tratamento de biofilmes". métodos para tratar ou reduzir biofilmes, trtando um distúrbio relacionado a biofilme e impedindo a formação de biofilme usando d-aminoácidos, são descritos.
BR112012016749A 2010-01-08 2011-01-10 "d-aminoácido para uso no tratamento de biofilmes" BR112012016749A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29341410P 2010-01-08 2010-01-08
US32993010P 2010-04-30 2010-04-30
PCT/US2011/020705 WO2011085326A1 (en) 2010-01-08 2011-01-10 D- amino acids for use in treating biofilms

Publications (1)

Publication Number Publication Date
BR112012016749A2 true BR112012016749A2 (pt) 2018-06-12

Family

ID=43838150

Family Applications (2)

Application Number Title Priority Date Filing Date
BRBR112012016869-0A BR112012016869A2 (pt) 2010-01-08 2011-01-10 Método e revestimentos para tratar biofilmes.
BR112012016749A BR112012016749A2 (pt) 2010-01-08 2011-01-10 "d-aminoácido para uso no tratamento de biofilmes"

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BRBR112012016869-0A BR112012016869A2 (pt) 2010-01-08 2011-01-10 Método e revestimentos para tratar biofilmes.

Country Status (9)

Country Link
US (2) US20130059096A1 (pt)
EP (2) EP2521448A1 (pt)
JP (2) JP2013516492A (pt)
KR (2) KR20120115375A (pt)
CN (2) CN103025158A (pt)
AU (2) AU2011203862A1 (pt)
BR (2) BR112012016869A2 (pt)
MX (2) MX2012008017A (pt)
WO (2) WO2011109119A1 (pt)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2684150C (en) 2007-05-14 2016-10-04 Research Foundation Of State University Of New York Decenoic acid dispersion inducers in the treatment of biofilms
US9034812B2 (en) * 2011-08-26 2015-05-19 Ohio University Compositions and methods for treating biofilms
DE102011085366A1 (de) 2011-10-28 2013-05-02 Henkel Ag & Co. Kgaa Biofilmreduzierende Spezialzahncreme
US20130108560A1 (en) * 2011-11-01 2013-05-02 Robert Davidson Chemical Treatments for the Disruption of Dental Plaque Biofilms and Related Methods
US9549904B2 (en) 2012-06-06 2017-01-24 Thomas Bryan Method of destroying bacterial biofilm using sterile intravenous or intracavernous glycerin
US9480669B2 (en) 2015-01-06 2016-11-01 The Regents Of The University Of California Method of destroying and preventing bacterial and fungal biofilm by amino acid infusion
WO2013126814A1 (en) * 2012-02-24 2013-08-29 Burzell Cynthia K Compounds for inhibition of biofilms
US8900338B2 (en) 2012-08-07 2014-12-02 Honeywell International Inc. Accessory cap for a respiratory filter cartridge
WO2014026052A1 (en) * 2012-08-08 2014-02-13 Vanderbilt University Composition with biofilm dispersal agents
US20150165340A1 (en) * 2012-09-03 2015-06-18 Laminar Co., Ltd. Purification System Comprising Continuous Reactor and Purification Method Using Continuous Reactor
KR101977711B1 (ko) 2012-10-12 2019-05-13 삼성전자주식회사 깊이 센서, 이의 이미지 캡쳐 방법, 및 상기 깊이 센서를 포함하는 이미지 처리 시스템
US9616008B2 (en) * 2012-12-20 2017-04-11 LIVIONEX, Inc. Antimicrobial compositions
CN103083291B (zh) * 2012-12-31 2014-11-26 中山大学 一种提高细菌对血清敏感性的物质
EP2803372A1 (en) 2013-05-16 2014-11-19 Universiteit Twente Process for the preparation of an object supporting a lipid bilayer
WO2014205096A1 (en) * 2013-06-18 2014-12-24 Novozymes A/S Bacterial mutants with improved transformation efficiency
JP2015155534A (ja) * 2014-01-17 2015-08-27 住友重機械工業株式会社 バイオフィルム分解剤及びバイオフィルムの分解方法
EP3283136B1 (en) * 2015-04-16 2021-06-02 Hollister Incorporated Hydrophilic coatings and methods of forming the same
WO2017192200A1 (en) 2016-05-05 2017-11-09 The Research Foundation For The State Unversity Of New York Compositions for treating periodontitis and dental calculus accumulation
CN109890205A (zh) * 2016-08-28 2019-06-14 以色列农业和农村发展部农业研究组织(范卡尼中心) 控制植物中的真菌感染的方法
CA3135553C (en) * 2016-10-04 2024-05-21 University Of Florida Research Foundation, Incorporated Amino acid compositions and uses thereof
CN106492640A (zh) * 2016-11-18 2017-03-15 哈尔滨商业大学 基于生物信息学减缓膜生物污染的方法
JP2018127427A (ja) * 2017-02-10 2018-08-16 味の素株式会社 唾液分泌促進剤、ならびにこれを配合した食品組成物、および口腔用組成物
WO2018226987A1 (en) 2017-06-07 2018-12-13 The Regents Of The University Of California Compositions for treating fungal and bacterial biofilms and methods of using the same
WO2019070759A1 (en) * 2017-10-02 2019-04-11 University Of Florida Research Foundation Incorporated AMINO ACID COMPOSITIONS AND METHODS FOR TREATING CYSTIC FIBROSIS
WO2019075202A2 (en) * 2017-10-11 2019-04-18 California Institute Of Technology METHODS AND SYSTEM FOR INTERFERING WITH THE VIABILITY OF BACTERIA, ASSOCIATED ANTIMICROBIALS, AND COMPOSITIONS
CN107998453B (zh) * 2017-12-12 2020-09-25 中山大学附属第一医院 一种表面改性的脱细胞基质及其改性方法
US20210106708A1 (en) * 2018-03-21 2021-04-15 Case Western Reserve University Thermoresponsive compositions and methods for preventing and disrupting biofilms
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
CN112533579A (zh) * 2018-07-16 2021-03-19 3M创新有限公司 通过减少口腔生物膜中的乳酸释放来治疗龋齿的含氨基酸口腔护理组合物
CN109055481B (zh) * 2018-08-21 2022-01-11 浙江海洋大学 一种纺锤水蚤体表附着细菌的检测方法
CN109221240A (zh) * 2018-11-01 2019-01-18 西安石油大学 一种水系统用抑制并分解生物膜的高效复合杀菌缓蚀剂
CN110064075B (zh) * 2019-04-23 2020-10-13 北京科技大学 一种基于纳米银/d-半胱氨酸的自组装抗菌涂层及制备方法
CN110590188B (zh) * 2019-08-29 2020-12-18 泰山玻璃纤维邹城有限公司 玻璃纤维废丝粉料的加工方法
US20220395442A1 (en) * 2019-11-08 2022-12-15 Colgate-Palmolive Company Methods of Modifying Biofilm
EP4072686A1 (en) 2019-12-12 2022-10-19 3M Innovative Properties Company Oral care composition with n-acetyl amino acid components for treating caries
EP3848017A1 (en) 2020-01-08 2021-07-14 3M Innovative Properties Company Oral care composition containing indole components for treating caries
CN111840103B (zh) * 2020-08-10 2023-04-07 黑龙江天龙药业有限公司 一种用于腋下的长效膜剂及其制备方法
CN116348087A (zh) * 2020-09-29 2023-06-27 联合利华知识产权控股有限公司 包含氨基酸的个人护理组合物
CN112022843B (zh) * 2020-10-20 2021-11-23 中国医科大学附属口腔医院 D-亮氨酸和氯己定组合物的应用
EP4301141A1 (en) * 2021-03-01 2024-01-10 Carlo Ratti Combination therapy for treatment of conditions associated with aging
KR102393943B1 (ko) * 2021-03-23 2022-05-02 주식회사 엘지생활건강 피부 및 두피 케어용 바이오필름 제거 조성물
CN113546895A (zh) * 2021-06-11 2021-10-26 浙江万陌科技有限公司 一种清洗装置
CN114100378B (zh) * 2021-10-20 2023-03-03 山东大学 一种具有磁靶向-磁热功能的d-氨基酸热敏控释纳米微粒及在mbr膜污染上的应用
CN114223727A (zh) * 2021-12-30 2022-03-25 浙江工商大学 一种d-色氨酸卤水凝胶及其应用
WO2023240339A1 (en) * 2022-06-13 2023-12-21 Daniela Fischer Russell Oral health agent and composition for use in domestic animals

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
EP0500712A1 (de) * 1989-11-16 1992-09-02 Henkel Kommanditgesellschaft auf Aktien Bekämpfung von schleimbildenden mikroorganismen
JPH06256186A (ja) * 1993-03-05 1994-09-13 Morishita Roussel Kk 癌用アミノ酸製剤
JPH06256184A (ja) * 1993-03-05 1994-09-13 Morishita Roussel Kk 癌患者用アミノ酸製剤
JP3828612B2 (ja) 1996-05-24 2006-10-04 東レ・ダウコーニング株式会社 液状シリコーンゴム組成物およびその製造方法
US7144862B2 (en) * 2000-08-24 2006-12-05 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
US7723303B2 (en) * 2000-08-24 2010-05-25 The Regents Of The University Of California Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
WO2002088298A1 (en) * 2001-04-27 2002-11-07 The Procter & Gamble Company Compounds, compositions, and methods for controlling biofilms
DE10251184A1 (de) 2002-11-04 2004-05-13 Degussa Ag Mutanten zur Herstellung von D-Aminosäuren
WO2005120489A2 (en) * 2004-06-04 2005-12-22 Molecular Therapeutics, Inc. Treatment of central nervous system disorders or injuries with d-methionine
US7271239B2 (en) * 2004-09-01 2007-09-18 The Research Foundation Of State University Of New York D-isomers of antimicrobial peptide
US7618697B2 (en) 2005-09-26 2009-11-17 Ciba Specialty Chemicals Corporation Carboxylic acid esters of zosteric acid for prevention of biofouling
US20070244449A1 (en) * 2005-10-06 2007-10-18 Novacal Pharmaceuticals, Inc. System and method for the prevention of bacterial and fungal infections including Urinary Tract Infections (UTI) using N-halogenated amino acids
WO2008098245A2 (en) * 2007-02-09 2008-08-14 University Of Georgia Reseach Foundation, Inc. Nmda receptor modulation and treatments for addictive behavior
BRPI0814412A2 (pt) * 2007-07-06 2017-05-23 Laclede Inc uso de enzimas hidrolíticas e oxidativas para dissolver biofilme nas passagens das vias aéreas
IL188681A0 (en) * 2008-01-09 2008-12-29 Amino Acid Solutions Inc Pharmaceutical compositions and methods utilizing a d-amino acid
CN101938954A (zh) * 2008-02-08 2011-01-05 高露洁-棕榄公司 擦齿巾

Also Published As

Publication number Publication date
MX2012008017A (es) 2012-10-03
MX2012008018A (es) 2012-10-03
AU2011221564A1 (en) 2012-07-26
WO2011085326A1 (en) 2011-07-14
CN103025158A (zh) 2013-04-03
KR20120115375A (ko) 2012-10-17
BR112012016869A2 (pt) 2015-09-01
US20130071439A1 (en) 2013-03-21
EP2521448A1 (en) 2012-11-14
WO2011109119A1 (en) 2011-09-09
CN102791262A (zh) 2012-11-21
US20130059096A1 (en) 2013-03-07
WO2011085326A9 (en) 2013-10-24
JP2013516297A (ja) 2013-05-13
KR20120113259A (ko) 2012-10-12
EP2521542A1 (en) 2012-11-14
AU2011203862A1 (en) 2012-07-26
JP2013516492A (ja) 2013-05-13

Similar Documents

Publication Publication Date Title
BR112012016749A2 (pt) "d-aminoácido para uso no tratamento de biofilmes"
CY1120557T1 (el) Μορια δεσμευσης anti-pseudomonas psl και χρησεις αυτων
EA201270803A1 (ru) Тиоацетатные соединения, композиции на их основе и способы их применения
EA201791850A1 (ru) Борсодержащие малые молекулы
EA201400993A1 (ru) Антитела против рецептора эпидермального фактора роста, активные в определенных условиях, и способы их применения
EA201200793A1 (ru) Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин
CL2011000043A1 (es) Compuestos derivados de benzoazepina sustituidos; compuestosintermediarios; metodo de sintesis; composicion farmaceutica; y uso en el tratamiento o prevencion de un trastorno del sistema nervioso central.
EA201200951A1 (ru) Определенные триазолопиридины и триазолопиразины, их композиции и способы их применения
EA201171367A1 (ru) Винилиндазолильные соединения
EA201001847A1 (ru) Соединения и композиции, применяемые для лечения малярии
MX354137B (es) Composiciones topicas de minociclina y metodos de uso de la misma.
RS53124B (en) USE OF BETANECOL FOR THE TREATMENT OF XEROSOMOMY
BR112013007229A2 (pt) ''composição,mistura e processo''.
EA201200484A1 (ru) Фармацевтическая композиция с действующими веществами - метформином и ситаглиптином или вилдаглиптином
EA201490559A1 (ru) Композиция для лечения свища
CL2008000896A1 (es) Composicion que mantiene el cuidado bucal periodico que comprende un aminoacido basico; uso en el tratamiento terapeutico de la superficie bucal.
MA32544B1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
RS53466B (en) USE OF AMISULPRID FOR THE TREATMENT OF POSTOPERATIVE Nausea and Vomiting
CL2009000119A1 (es) Compuestos derivados de amino-bencimidazoles sustituidos; composicion farmaceutica; y su uso en el tratamiento del alzheimer.
BR112013004850A2 (pt) tratamento de infarto do miocárdio usando antagonistas tgf-beta
WO2012158672A3 (en) Compounds for use in treatment of mucositis
BR112014011481A2 (pt) hidrolisado de colágeno e seu uso
MX2014010940A (es) El uso de antitrombina en el tratamiento de preeclampsia.
BR112014026483A2 (pt) composição antimicrobiana, composição antimicrobiana bicomponente, pano de limpeza, método para desinfetar uma superfície e método para controlar esporos sobre uma superfície
ATE538799T1 (de) Zusammensetzungen zur behandlung von haarverlust

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2476 DE 19-06-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]